Published in JAMA on September 06, 1976
Respiratory syncytial virus infection in adults. Clin Microbiol Rev (2000) 3.16
The clinical course of acquired complete heart block in children with acute myocarditis. Pediatr Cardiol (2003) 1.12
Cardiogenic Shock and Respiratory Failure in a Patient With Metastatic Melanoma Receiving Trametinib Therapy. Oncologist (2016) 0.77
Prolonged sinoatrial block in an infant with respiratory syncytial viral bronchiolitis. Pediatr Cardiol (2012) 0.75
Patent foramen ovale: a review of associated conditions and the impact of physiological size. J Am Coll Cardiol (2001) 1.80
Echocardiographic diagnosis of left atrial myxoma. Am J Cardiol (1974) 1.56
Randomized placebo-controlled trial of amlodipine in vasospastic angina. Amlodipine Study 160 Group. J Am Coll Cardiol (1993) 1.45
Remodeling and reparation of the cardiovascular system. J Am Coll Cardiol (1992) 1.41
Death associated with ventricular arrhythmia and thioridazine hydrochloride. JAMA (1968) 1.40
Acute posterior multifocal placoid pigment epitheliopathy associated with an adenovirus type 5 infection. Am J Ophthalmol (1975) 1.19
The role of viruses in the production of heart disease. Am J Cardiol (1972) 1.18
Nifedipine-associated myocardial ischemia or infarction in the treatment of hypertensive urgencies. Ann Intern Med (1987) 1.13
The cardiomyopathy of hypoparathyroidism. Another reversible form of heart muscle disease. Chest (1981) 1.10
Alcoholic cardiomyopathy. Concept of the disease and its treatment. Am J Med (1971) 1.08
Echocardiographic diagnosis of vegetative aortic bacterial endocarditis. Am J Cardiol (1974) 1.06
Human antibody to influenza C virus: its age-related distribution and distinction from receptor analogs. Infect Immun (1980) 1.06
Ischemic cardiomyopathy. Am Heart J (1970) 1.05
Hand-foot-and-mouth-disease resembling measles a life-threatening disease: case report. Pediatrics (1966) 0.98
Achieving blood pressure goals globally: five core actions for health-care professionals. A worldwide call to action. J Hum Hypertens (2007) 0.94
Human and rat neutrophils constitutively express neural nitric oxide synthase mRNA. Nitric Oxide (1998) 0.94
A comparison of four commercial test kits for detection of cytomegalovirus antibodies in blood donors. Transfusion (1986) 0.93
Effects of ethanol on neutrophil recruitment and lung host defense in nitric oxide synthase I and nitric oxide synthase II knockout mice. Alcohol Clin Exp Res (1999) 0.92
Sensitivity of HTLV-I antibody assays for HTLV-II. Lancet (1991) 0.91
Hemodynamic and renal effects of atrial natriuretic peptide in congestive heart failure. Am J Cardiol (1990) 0.91
Nuggets, pearls, and vignettes of master heart failure clinicians. Part 2-the physical examination. Congest Heart Fail (2002) 0.89
Postpartal cardiomyopathy. Cardiovasc Clin (1972) 0.88
Nitro containing L-arginine analogs interfere with assays for nitrate and nitrite. Life Sci (1995) 0.88
Cold hypersensitivity. Arch Intern Med (1974) 0.87
Calcium antagonists: an overview. Angiology (1982) 0.86
The burden of a hot and humid environment on the heart. Mod Concepts Cardiovasc Dis (1970) 0.85
The importance of magnesium deficiency in cardiovascular disease. Am Heart J (1977) 0.84
Enteroviruses in rural families and their domestic animals. Am J Epidemiol (1970) 0.84
Multiclinic controlled trial of diltiazem for Prinzmetal's angina. Am J Med (1982) 0.84
Effect of mibefradil, a T-type calcium channel blocker, on morbidity and mortality in moderate to severe congestive heart failure: the MACH-1 study. Mortality Assessment in Congestive Heart Failure Trial. Circulation (2000) 0.84
Fatal pneumonia caused by adenovirus type 35. Am J Dis Child (1981) 0.82
Effects of NO synthase inhibitors, arginine-deficient diet, and amiloride in pregnant rats. Am J Physiol (1997) 0.81
Cardiopulmonary pharmacology of enkephalins in the conscious dog. Peptides (1981) 0.81
Heart failure in diabetes mellitus: causal and treatment considerations. Minerva Cardioangiol (2004) 0.80
Modern evaluation of the hypertensive patient: autonomic tone in cardiovascular disease and the assessment of heart rate variability. Blood Press Monit (1999) 0.80
Interactions between circulating peptides and the central nervous system in hemodynamic regulation. Am J Cardiol (1989) 0.80
Short-term effects of intravenous clonidine in congestive heart failure. Clin Pharmacol Ther (1981) 0.80
Hemodynamic alterations produced by prolonged urethane anesthesia in the intact dog. Am Heart J (1969) 0.80
Limitations of ergonovine testing in patients with variant angina. Cathet Cardiovasc Diagn (1982) 0.80
Comparative cardiovascular responses to intravenous capsaicin, phenyldiguanide, veratrum alkaloids and enkephalins in the conscious dog. J Auton Pharmacol (1986) 0.79
Tolerance development to the arousal effects of nicotine. Pharmacol Biochem Behav (1975) 0.79
Interaction of ethanol with inducible nitric oxide synthase messenger RNA and protein: direct effects on autacoids and endotoxin in vivo. J Pharmacol Exp Ther (1997) 0.79
Coronary artery pain. A possible cause of graft occlusion in a patient with fixed obstructive coronary artery disease. Arch Intern Med (1980) 0.79
Influence of alcohol on the cardiovascular response to isometric exercise in normal subjects. Angiology (1982) 0.79
Enkephalin analogs and dermorphin in the conscious dog: structure-activity relationships. Peptides (1983) 0.79
A double-blind comparison of lisinopril with captopril in patients with symptomatic congestive heart failure. J Cardiovasc Pharmacol (1987) 0.79
Antianginal effects of clonidine. J Cardiovasc Pharmacol (1986) 0.79
Angle of traction of the papillary muscle in normal and dilated hearts: a theoretic analysis of its importnace in mitral valve dynamics. Am Heart J (1972) 0.79
Isolation of parainfluenza virus type 3 from cerebrospinal fluid associated with aseptic meningitis. Am J Clin Pathol (1993) 0.79
Acute and short-term effects of clonidine in heart failure. Angiology (1987) 0.79
Angiotensin-converting enzyme inhibitors and angiotensin II receptor antagonists in the treatment of heart failure caused by left ventricular systolic dysfunction. Prog Cardiovasc Dis (1999) 0.79
A cytologic study of chronic bronchitis. Am Rev Respir Dis (1970) 0.79
The influence of anesthesia on hemodynamic responses to glucagon in intact dog. Proc Soc Exp Biol Med (1971) 0.79
Differential effects of L-N5-(1-iminoethyl)-ornithine on tone and endothelium-dependent vasodilator responses. Am J Physiol (1997) 0.78
Prolonged bed rest in the management of patients with cardiomyopathy. Cardiovasc Clin (1972) 0.78
The prolonged effect of pentaerythritol tetranitrate on exercise capacity in stable effort angina pectoris. Chest (1981) 0.78
Roentgenogram of the month: angina pectoris associated with a metallic fragment in the heart. Chest (1979) 0.78
The effects of barbiturates upon the hemodynamic responses to intravenous methionine-enkephalin in dogs: modulation by the GABA complex. Peptides (1986) 0.78
Detection of right to left shunts in decompression sickness in divers. Am J Cardiol (1997) 0.78
Ethanol inhibits inducible nitric oxide synthase transcription and post-transcriptional processes in vivo. Alcohol Clin Exp Res (1997) 0.78
Efficacy and safety of amlodipine in vasospastic angina: an interim report of a multicenter, placebo-controlled trial. The Investigators of Study 160. Am Heart J (1989) 0.77
Intravenous captopril in congestive heart failure. J Clin Pharmacol (1990) 0.77
Anesthesia, dogs, and cardiovascular data. Am Heart J (1970) 0.77
Electrocardiographic changes in acute pancreatitis. South Med J (1982) 0.77
Hemodynamic actions of endothelin in conscious and anesthetized dogs. Peptides (1989) 0.77
Non-opiate and peripheral-opiate cardiovascular effects of morphine in conscious dogs. Life Sci (1986) 0.77
Efficacy of nicardipine in angina pectoris. J Clin Pharmacol (1990) 0.77
Comparison of nitrendipine and hydrochlorothiazide for systemic hypertension. Am J Cardiol (1987) 0.77
Pathogenesis of "rheumatic" heart disease:critique and theory. Am Heart J (1970) 0.77
Respiratory failure complicated by adenovirus serotype 29 in a patient with AIDS. J Infect Dis (1989) 0.77
Endothelin produces systemic vasodilation independent of the state of consciousness. Peptides (1990) 0.76
Lisinopril versus placebo in the treatment of heart failure: the Lisinopril Heart Failure Study Group. J Clin Pharmacol (1995) 0.76
Alpha-adrenergic mechanisms in the pathophysiology of left ventricular heart failure--an analysis of their role in systolic and diastolic dysfunction. J Mol Cell Cardiol (1986) 0.76
Failure of interleukin-2 to alter systolic blood pressure in Dahl salt-sensitive rats. Am J Hypertens (1992) 0.76
New WHO/ISFC classification of cardiomyopathies: a task not completed. Circulation (1997) 0.76
Coronary vasodilator responses to bradykinin in euglycemic and diabetic rats. Am J Hypertens (2001) 0.76
Dissociation of TNF-alpha from endotoxin-induced nitric oxide and acute-phase hypotension. Am J Physiol (1997) 0.76
Clonidine and heart failure. Hypertension (1996) 0.75
The effect of area postrema lesions on hemodynamic responses to systemic methionine-enkephalin in conscious dogs. Am J Hypertens (1988) 0.75
Mexiletine: long-term follow-up of a patient with prolonged QT interval and quinidine-induced torsades de pointes. South Med J (1985) 0.75
Methionine-enkephalin does not alter human platelet aggregatory response. Thromb Res (1985) 0.75
Central alpha-adrenergic agonists in chronic heart failure and ischemic heart disease. J Cardiovasc Pharmacol (1985) 0.75
Racial differences in platelet survival time in patients with symptomatic coronary atherosclerosis. Arteriosclerosis (1983) 0.75
A digital rheoplethysmographic study of the vasomotor response to 'simulated diving' in man. Cardiology (1972) 0.75
A critique of the cardiac index. Am Heart J (1971) 0.75
Ischemic cardiomyopathy. South Med J (1972) 0.75
Mechanism of the cardiovascular response to systemic intravenous administration of leucine-enkephalin in the conscious dog. Peptides (1983) 0.75
Immunoreactive plasma concentrations of an endogenous antiopiate are higher in spontaneously hypertensive rats than in Wistar-Kyoto rats. Hypertension (1986) 0.75
Experimental evidence in man of the electrocardiographic manifestations of papillary muscle dysfunction. Am Heart J (1971) 0.75
The influence of the inter-dose time interval on the cardiovascular response to methionine-enkephalin in the conscious dog. Peptides (1984) 0.75
Interactions of leucine-enkephalin with alpha-adrenoceptors in the conscious dog. Chest (1983) 0.75
The effect of intravenous clonidine hydrochloride on the isolated forearm venous segment in heart failure. Chest (1983) 0.75
Ventilatory response to intravenous methionine enkephalin in awake dogs. J Pharmacol Exp Ther (1985) 0.75
Cardiovascular activities of intravenous methionine-enkephalin-Arg6-Phe7 and methionine-enkephalin-Arg6-Gly7-Leu8 in the conscious dog. Life Sci (1985) 0.75
Methionine-enkephalin facilitates the cardiovascular response to epinephrine in the conscious dog. Peptides (1984) 0.75
Time-dependent antihypertensive effect of carteolol--a beta-adrenoceptor antagonist with partial agonist activity. Clin Pharmacol Ther (1984) 0.75
Cardiovascular interactions between methionine-enkephalin and substance P in the conscious dog. Peptides (1985) 0.75
Elevation of arterial blood pressure in conscious dogs by Des-Tyr1-D-Ala2-leucine-enkephalinamide. Biochem Pharmacol (1982) 0.75
Acute encephalopathy in twins due to adenovirus type 7 infection. Arch Neurol (1983) 0.75
MIF-1 does not act like naloxone in antagonizing the cardiovascular activity of leucine-enkephalin in the conscious dog. Pharmacol Biochem Behav (1982) 0.75